AC Immune Receives FDA Fast Track Designation for Anti-Alpha-synuclein Active Immunotherapy, ACI-7104, to Treat Early Parkinson’s Disease (PD)

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/22/2026

1. SPY
2. WBD
3. PSKY
4. NVDA
5. TSLA
6. USO
7. AMD
8. COHR
9. META
10. AMC

Go back to AC Immune Receives FDA Fast Track Designation for Anti-Alpha-synuclein Active Immunotherapy, ACI-7104, to Treat Early Parkinson’s Disease (PD)
(NASDAQ: ACIU) Delayed: 2.66 +0.03 (1.14%)
Previous Close $2.63    52 Week High $19.97 
Open $2.63    52 Week Low $10.36 
Day High $2.72    P/E N/A 
Day Low $2.57    EPS $0.00 
Volume 109,426       

(NASDAQ: ACIU) Delayed: 2.66 +0.03 (1.14%)
Previous Close $2.63    52 Week High $19.97 
Open $2.63    52 Week Low $10.36 
Day High $2.72    P/E N/A 
Day Low $2.57    EPS $0.00 
Volume 109,426